GleamWall
中文EN

LMAT LEMAITRE VASCULAR INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1158895 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.8%
TTM net income YoY18.7%
TTM EPS YoY18.5%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR32.4%

Margins

Gross margin72.0%
Operating margin27.7%
Net margin23.5%
FCF margin24.9%
EBITDA margin31.7%

Returns

ROE15.6%
ROA10.1%
ROIC (approx.)15.3%
Asset turnover0.43x

Leverage & solvency

Liabilities / assets34.1%
Debt / equity0.00x
Current ratio14.60x
Interest coverage14.35x

Cash quality & payout

Operating cash flow / net income1.20x
Accruals ratio-2.1%
Payout ratio34.2%
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$249.60M$219.86M
Cost of revenue$71.06M$68.96M
Gross profit$178.54M$150.90M
R&D expense$14.14M$15.65M
SG&A expense$42.02M$36.26M
Operating income$67.91M$52.26M
Interest expense$5.18M$205,000
Pretax income$75.18M$56.88M
Income tax$17.45M$12.84M
Net income$57.73M$44.04M
EBITDA$78.33M$61.86M
EPS (basic)2.551.96
EPS (diluted)2.521.93
Dividends declared per share0.800.64
Weighted avg. shares (diluted)22.93M22.78M
Balance sheet
Cash & equivalents$28.24M$25.61M
Short-term investments$330.88M$274.11M
Receivables$33.61M$30.06M
Current assets$468.23M$402.19M
PP&E, net$27.00M$24.80M
Goodwill$65.94M$65.94M
Intangibles$33.09M$35.82M
Total assets$615.69M$551.82M
Current liabilities$36.32M$30.61M
Total liabilities$222.17M$214.53M
Shareholders' equity$393.52M$337.29M
Shares outstanding22.77M22.55M
Cash flow statement
Operating cash flow$81.25M$44.12M
Capital expenditure$6.78M$6.96M
Free cash flow$74.47M$37.16M
Investing cash flow-$64.94M-$200.12M
Financing cash flow-$14.54M$158.10M
Depreciation & amortization$10.42M$9.61M
Stock-based compensation$7.83M$6.57M
Dividends paid$18.11M$14.38M
Share buybacks$1.82M$1.72M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.